Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.

Area of Science:

• Medical Ethics
• Pharmacology
• Regulatory Science

Background:

• Medical drugs and devices approved by the FDA can be legally used for unapproved purposes.
• Manufacturer promotion of these unapproved uses is illegal.
• Off-label use presents both potential patient benefits and significant risks.

Purpose of the Study:

• To review the ethical considerations of off-label use of FDA-approved therapies.
• To examine the implications of illegal off-label marketing by manufacturers.
• To provide guidance for physicians prescribing off-label therapies.

Main Methods:

• Literature review focusing on off-label drug and device utilization.
• Analysis of regulatory guidelines and ethical frameworks concerning unapproved uses.
• Examination of risks and benefits associated with off-label prescriptions.

Main Results:

• Off-label use can undermine FDA's safety mission and expose patients to unproven risks.
• Vulnerable populations (elderly, mental health patients, pregnant women, children) face amplified risks.
• Illegal marketing practices by manufacturers exacerbate safety concerns.

Conclusions:

• Careful consideration is crucial for physicians when prescribing off-label therapies.
• Off-label use necessitates a balance between potential patient benefit and established safety protocols.
• Addressing ethical issues and regulatory compliance is vital to protect patients.